J. Goldman & CO LP Celldex Therapeutics, Inc. Transaction History
J. Goldman & CO LP
- $3.21 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding CLDX
# of Institutions
197Shares Held
66MCall Options Held
1.68MPut Options Held
980K-
Wellington Management Group LLP Boston, MA9.24MShares$208 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$105 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.87MShares$87 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.46MShares$77.7 Million9.64% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$74.9 Million1.99% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.05B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...